Caris Life Sciences (CAI) Other financing activities (2024 - 2026)

Caris Life Sciences' Other financing activities history runs 3 years deep, the most recent figure standing at $920000.0 for Q1 2026.

• In Q1 2026, Other financing activities fell 35.84% year-over-year to $920000.0; the TTM figure through Mar 2026 stood at $527.9 million (changed N/A YoY), while the FY2025 annual figure was $528.5 million, changed N/A from the prior year.
• Other financing activities for Q1 2026 stood at $920000.0, down from $518.2 million in the prior quarter.
• The five-year high for Other financing activities was $518.2 million in Q4 2025, with the low at -$1.3 million in Q4 2024.
• The 3-year median for Other financing activities is $1.2 million (2025), against an average of $75.5 million.
• The sharpest annual moves came in 2025 and 2026: Other financing activities jumped 41291.49% in 2025, then tumbled 35.84% in 2026.
• Caris Life Sciences' Other financing activities stood at -$1.3 million in 2024, then surged by 41291.49% to $518.2 million in 2025, then tumbled by 99.82% to $920000.0 in 2026.
• Business Quant data shows CAI's Other financing activities at $920000.0 in Q1 2026, $518.2 million in Q4 2025, and $7.6 million in Q3 2025.